Paradigm Biopharmaceuticals | PAR - Sales Revenues

Stock Price
0.20
Daily Change
0.01 2.63%
Monthly
-25.00%
Yearly
-33.90%
Q2 Forecast
0.22

Paradigm Biopharmaceuticals reported AUD284.06K in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Avita Medical AUD 17.61M 805K Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025